Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Feasibility study of screening for bladder cancer with urinary molecular markers (the BLU-P project).

Urologic oncology - 1 Jan 2000

Roobol M J, Bangma C H, el Bouazzaoui S, Franken-Raab Conja G, Zwarthoff Ellen C

Abstract excerpt

INTRODUCTION: The prognosis of bladder cancer (BC) depends mainly on its histology, grade, and stage. Patients with superficial BC (70% of the urothelial carcinomas) have a relatively good prognosis, but patients diagnosed with invasive, high grade BC, and those who progress to invasive BC, have a poor prognosis and will not survive their disease in many cases due to their metastases, despite the currently...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to DNA Methylation
Share to Early Detection of Cancer

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Feasibility Studies

Share to Hematuria

Share to Mass Screening

Share to Nuclear Proteins

Share to Receptor, Fibroblast Growth Factor, Type 3

Share to Urinary Bladder Neoplasms

Source

Identifiers

PMID: 21062653
DOI: 10.1016/j.urolonc.2009.12.002

Genes

FGFR3

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Feasibility study of screening for bladder cancer with urinary molecular markers (the BLU-P project).PMID 21062653Read ↗

Bladder cancer detection in urine by novel methylation markersSemantic proximity Read ↗

A systematic review on mutation markers for bladder cancer diagnosis in urine.Semantic proximity Read ↗

Trends in urine biomarker discovery for urothelial bladder cancer: DNA, RNA, or protein?Semantic proximity Read ↗

Molecular markers for detection, surveillance and prognostication of bladder cancer.Semantic proximity Read ↗

[Molecular diagnostics of bladder cancer-practical ramifications].Semantic proximity Read ↗

Diagnostic Potential of Circulating Tumor Cells, Urinary MicroRNA, and Urinary Cell-Free DNA for Bladder Cancer: A ReviewSemantic proximity Read ↗

microRNA profiles in urine by next-generation sequencing can stratify bladder cancer subtypesSemantic proximity Read ↗

GALEAS™ Bladder Demonstrates High Sensitivity and Specificity for Detecting Bladder Cancer: Real-World Multicentre Data from UK NHS Haematuria ClinicsSemantic proximity Read ↗

Current and emerging bladder cancer biomarkers with an emphasis on urine biomarkersSemantic proximity Read ↗

TP53 Mutation for Prediction of Tumor Recurrence and Metastasis in Bladder Cancer PatientsSemantic proximity Read ↗

Gene-based urinary biomarkers for bladder cancer: an unfulfilled promise?Semantic proximity Read ↗

Potential new urinary markers in the early detection of bladder cancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.